These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2848567)
1. Attenuation of pulmonary leukocyte sequestration during extracorporeal circulation by a new c-AMP phosphodiesterase inhibitor. Ohtani M; Matsuda H; Shirakura R; Sawa Y; Matsuwaka R; Kuki S; Nakano S; Kawashima Y ASAIO Trans; 1988; 34(3):761-4. PubMed ID: 2848567 [TBL] [Abstract][Full Text] [Related]
2. Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury. Chang-Chun C; Matsuda H; Sawa Y; Kaneko M; Sakagoshi N; Nishimura M; Kuratani T; Amemiya A; Kawashima Y Ann Thorac Surg; 1991 Sep; 52(3):495-9. PubMed ID: 1654868 [TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase type 4 inhibition of activated polymorphonuclear leukocytes in a simulated extracorporeal circulation model. Sato Y; Hiramatsu Y; Homma S; Sato S; Onizuka M; Sakakibara Y J Thorac Cardiovasc Surg; 2003 Jan; 125(1):172-7. PubMed ID: 12539001 [TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation. Sato Y; Hiramatsu Y; Homma S; Sato M; Sato S; Endo S; Sohara Y J Thorac Cardiovasc Surg; 2005 Aug; 130(2):346-50. PubMed ID: 16077397 [TBL] [Abstract][Full Text] [Related]
5. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery. Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070 [TBL] [Abstract][Full Text] [Related]
6. [Behavior of platelets and leukocytes on the luminal surface of small caliber prosthetic grafts]. Matsumoto M Nihon Geka Hokan; 1988 Sep; 57(5):351-9. PubMed ID: 2855195 [No Abstract] [Full Text] [Related]
7. Effects of DN-9693, a selective inhibitor of cyclic AMP phosphodiesterase, in isolated and perfused canine large coronary arteries. Nakane T; Chiba S Jpn J Pharmacol; 1988 Dec; 48(4):507-9. PubMed ID: 2468805 [TBL] [Abstract][Full Text] [Related]
8. [Experimental study of the decrease in leukocytes and changes in leukotriene B4 caused by ECMO]. Hasegawa Y Nihon Kyobu Geka Gakkai Zasshi; 1991 Dec; 39(12):2126-33. PubMed ID: 1663532 [TBL] [Abstract][Full Text] [Related]
10. DN 9693: a phosphodiesterase inhibitor with a platelet membrane effect. Jackson C; Ball J; Peel J; Lawry J; Greaves M; Preston FE Thromb Haemost; 1989 Apr; 61(2):266-9. PubMed ID: 2546286 [TBL] [Abstract][Full Text] [Related]
11. Effects of DN-9693, a new metastasis inhibitor, on murine hematogenous metastasis. Tanaka NG; Tohgo A; Ogawa H; Osada Y Anticancer Res; 1986; 6(4):543-8. PubMed ID: 3019218 [TBL] [Abstract][Full Text] [Related]
12. Behavior of platelets and leukocytes on the luminal surface of small caliber polyurethane grafts. Matsumoto M; Ban T; Okamoto Y J Cardiovasc Surg (Torino); 1989; 30(4):609-13. PubMed ID: 2550468 [TBL] [Abstract][Full Text] [Related]